Preston R J, Au W, Bender M A, Brewen J G, Carrano A V, Heddle J A, McFee A F, Wolff S, Wassom J S
Mutat Res. 1981 Sep;87(2):143-88. doi: 10.1016/0165-1110(81)90030-0.
This report presents an assessment made by the U.S. Environmental Protection Agency Gene-Tox Program's Work Group on mammalian cytogenetics of the clastogenic effects of chemicals in in vivo and in vitro mammalian cell assays. This assessment is based on information provided by the Environmental Mutagen Information Center, Oak Ridge National Laboratory, with the proviso that the experimental protocol used in these papers was adjudged to be acceptable by standards outlined by the Work Group. Some data were accepted as "qualitative only" because the protocol used was fairly close to that proposed as suitable. Using these criteria, 177 papers were selected for review. 6 assays were reviewed: bone marrow (32 papers, 31 chemicals), spermatogonial (10 papers, 10 chemicals), spermatocyte (25 papers, 25 chemicals), oocyte or early embryo (18 papers, 19 chemicals), in vitro cell culture (30 papers, 66 chemicals), and leukocyte (66 papers, 53 chemicals). Each assay was considered separately, and comparisons were then made between them for their similarities or differences in producing a positive or negative clastogenic effect of a particular chemical or chemical class. A large proportion of the available cytogenetic data was not suitable for inclusion in the final data base because of poor experimental design or unsatisfactory reporting of the information. It was not possible to recommend any one assay for determining potential clastogenicity because each had its own particular advantages and limitations and provided unique information. For demonstrating in vivo effects, the bone-marrow assay is probably the simplest and most economical. If only in vitro exposures were considered, leukocytes or cultured mammalian cell lines would be suitable. However, there are advantages to using leukocytes because they are a synchronous population, at least through their cell division, and because of the ready availability of human cells. In general, there was good agreement between clastogenicity and carcinogenicity.
本报告展示了美国环境保护局基因毒性项目工作组对化学物质在体内和体外哺乳动物细胞试验中致断裂效应的哺乳动物细胞遗传学评估。该评估基于橡树岭国家实验室环境诱变信息中心提供的信息,前提是这些论文中使用的实验方案被工作组概述的标准判定为可接受。一些数据仅被视为“定性数据”,因为所使用的方案与提议的合适方案相当接近。使用这些标准,挑选了177篇论文进行审查。审查了6种试验:骨髓试验(32篇论文,31种化学物质)、精原细胞试验(10篇论文,10种化学物质)、精母细胞试验(25篇论文,25种化学物质)、卵母细胞或早期胚胎试验(18篇论文,19种化学物质)、体外细胞培养试验(30篇论文,66种化学物质)和白细胞试验(66篇论文,53种化学物质)。对每种试验分别进行了考虑,然后比较它们在产生特定化学物质或化学类别阳性或阴性致断裂效应方面的异同。由于实验设计不佳或信息报告不令人满意,大部分可用的细胞遗传学数据不适合纳入最终数据库。不可能推荐任何一种试验来确定潜在的致断裂性,因为每种试验都有其自身的特定优点和局限性,并提供独特的信息。对于证明体内效应,骨髓试验可能是最简单且最经济的。如果仅考虑体外暴露,白细胞或培养的哺乳动物细胞系将是合适的。然而,使用白细胞有其优势,因为它们是同步群体,至少在细胞分裂方面是这样,而且人类细胞易于获取。总体而言,致断裂性和致癌性之间有很好的一致性。